ArticleBioanalysis2024

Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum.

Joanne Goodman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.